Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis

Focus on Consumables, Platform, Techniques, Application, End User, and Region - Analysis and Forecast, 2021-2031

Published Year:
SKU: BHP0590SB

$ 5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Market Report Coverage

Cell-Free DNA Isolation and Extraction Market
Forecast Period: 2021-2031
CAGR During Forecast Period: 14.19%

Cell-Free DNA Isolation and Extraction Market

Base Year

2020

Market Size in 2021

$195.0 Million

Forecast Period

2021-2031

Value Projection and Estimation by 2031

$735.1 Million

CAGR During Forecast Period

14.19%

Number of Tables

06

Number of Pages

230

Number of Figures

208

Market Segmentation

•    Consumable - Cell-Free DNA Isolation and Extraction Kits, ell-Free DNA Isolation and Extraction Tubes, and Other Consumables

•    Platform - Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms

•    Technique - Magnetic Beads-Based, Spin Column-Based, and Other Techniques

•    Application - Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications

•    End-User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Other End Users

Regional Segmentation

•    North America - U.S., Canada

•    Europe - Germany, U.K., France, Italy, Spain, Denmark, and Rest-of-Europe

•    Asia-Pacific - China, India, Japan, Singapore, South Korea, Australia, and Rest-of-Asia-Pacific

•    Rest-of-the-World

Market Growth Drivers

•    Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer

•    Strategic Initiatives by Key Market Players

•    Rise in the Field of Microbial Sequencing

Market Challenges

•    High Cost of Automated Instruments

•    Genomic Data Protection

•    Rigid Regulatory Standards

Market Opportunities

•    Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction

•    Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

Key Companies Profiled

Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela Diagnostics

Key Questions Answered in this Report:

How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?

•    How is cell-free DNA isolation and extraction revolutionizing oncology?
•    What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
•    What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
•    How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?
•    What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
•    What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?
•    What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? 
•    How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
        o    Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables)
        o    Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms)
        o    Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques)
        o    Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications)
        o    End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users)
        o    Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
•    What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
•    Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market? 
•    Which companies are anticipated to be highly disruptive in the future, and why?

Report Summary

The market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031.

Market Overview

The use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market. The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market. The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.

Competitive Landscape

The global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types. Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.

Table of Contents

Download this TOC  

Request a Sample

1.1    Product Definition
         1.1.1    Inclusion and Exclusion
1.2    Market Scope
         1.2.1    Scope of the Study
         1.2.2    Key Questions Answered in the Report
1.3    Market Overview
         1.3.1    Market Definition
         1.3.2    Early Discovery and Application of cfDNA
         1.3.3    Properties of cfDNA
         1.3.4    Biological Role of cfDNA
         1.3.5    Extraction of Circulating cfDNA
         1.3.6    Application of Circulating cfDNA
         1.3.7    Market Footprint and Growth Potential
         1.3.8    Disruption in Global Cell-Free DNA Isolation and Extraction Market Due to COVID-19
         1.3.9    COVID-19 Affecting Supply Chain of Global Cell-Free DNA Isolation and Extraction Market
         1.3.10    Interruption in Research and Clinical Development and Commercial Operation
                       1.3.10.1    Research and Clinical Development
                       1.3.10.2    Commercial Operation
         1.3.11    Navigating Crisis Recovery and Looking to the Future

2.1    Overview
2.2    Legal Requirements and Framework in the U.S.
         2.2.1    FDA Regulation
2.3    Legal Requirements and Framework in Europe
2.4    Legal Requirements and Framework in Asia-Pacific
         2.4.1    China
         2.4.2    Japan

3.1    Overview
3.2    Impact Analysis
3.3    Market Drivers
         3.3.1    Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer
         3.3.2    Strategic Initiatives by Key Market Players
         3.3.3    Rise in the Field of Microbial Sequencing
3.4    Market Restraints
         3.4.1    High Cost of Automated Instruments
         3.4.2    Genomic Data Protection
         3.4.3    Rigid Regulatory Standards
3.5    Market Opportunities
         3.5.1    Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction
         3.5.2    Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

4.1    Overview
4.2    Product Launch and Upgradations
4.3    Product Approvals and Business Funding
4.4    Synergistic Activities
4.5    Mergers and Acquisitions
4.6    Market Share Analysis (by Company), 2019 and 2020
4.7    Growth Share Analysis (by Company)

5.1    Overview
5.2    Cell-Free DNA Isolation and Extraction Kits
5.3    Cell-Free DNA Isolation and Extraction Tubes
5.4    Other Consumables

6.1    Overview
6.2    Next-Generation Sequencing (NGS)
6.3    Polymerase Chain Reaction (PCR)
         6.3.1    Real-Time Polymerase Chain Reaction (RT-PCR)
         6.3.2    Digital Polymerase Chain Reaction (dPCR)
6.4    Other Platforms

7.1    Overview
7.2    Magnetic Beads-Based
7.3    Spin Column-Based
7.4    Other Techniques

8.1    Overview
8.2    Non-Invasive Prenatal Testing (NIPT)
8.3    Oncology
         8.3.1    Solid Tumor
         8.3.2    Hematological Malignancies
8.4    Transplant Rejection
8.5    Other Applications

9.1    Overview
9.2    Pharmaceutical and Biotechnology Companies
9.3    Academic Research Institutes and Laboratories
9.4    Contract Research Organizations (CROs)
9.5    Clinical Diagnostic Centers
9.6    Other End Users

10.1    Overview
10.2    North America
           10.2.1    U.S.
           10.2.2    Canada
10.3    Europe
           10.3.1    Germany
           10.3.2    France
           10.3.3    U.K.
           10.3.4    Italy
           10.3.5    Spain
           10.3.6    Denmark
           10.3.7    Rest-of-Europe
10.4    Asia-Pacific
           10.4.1    China
           10.4.2    India
           10.4.3    Japan
           10.4.4    South Korea
           10.4.5    Australia
           10.4.6    Singapore
           10.4.7    Rest-of-Asia-Pacific (RoAPAC)
10.5    Latin America
           10.5.1    Brazil
           10.5.2    Mexico
           10.5.3    Rest-of-Latin America (RoLA)
10.6    Rest-of-the-World

11.1    Overview
11.2    Thermo Fisher Scientific Inc.
           11.2.1    Company Overview
           11.2.2    Role of Thermo Fisher Scientific Inc. in the Global Cell-Free DNA Isolation and Extraction Market
           11.2.3    Financials
           11.2.4    Key Insights About the Financial Health of the Company
           11.2.5    SWOT Analysis
11.3    QIAGEN
           11.3.1    Company Overview
           11.3.2    Role of QIAGEN in the Global Cell-Free DNA Isolation and Extraction Market
           11.3.3    Financials
           11.3.4    Key Insights About the Financial Health of the Company
           11.3.5    SWOT Analysis
11.4    Danaher
           11.4.1    Company Overview
           11.4.2    Role of Danaher in the Global Cell-Free DNA Isolation and Extraction Market
           11.4.3    Financials
           11.4.4    Key Insights About the Financial Health of the Company
           11.4.5    SWOT Analysis
11.5    PerkinElmer, Inc.
           11.5.1    Company Overview
           11.5.2    Role of PerkinElmer, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
           11.5.3    Financials
           11.5.4    Key Insights About the Financial Health of the Company
           11.5.5    SWOT Analysis
11.6    Endress+Hauser AG
           11.6.1    Company Overview
           11.6.2    Role of Endress+Hauser AG in the Global Cell-Free DNA Isolation and Extraction Market
           11.6.3    Financials
           11.6.4    Key Insights About the Financial Health of the Company
           11.6.5    SWOT Analysis
11.7    Agilent Technologies, Inc.
           11.7.1    Company Overview
           11.7.2    Role of Agilent Technologies, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
           11.7.3    Financials
           11.7.4    Key Insights About the Financial Health of the Company
           11.7.5    SWOT Analysis
11.8    F. Hoffmann-La Roche Ltd.
           11.8.1    Company Overview
           11.8.2    Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free DNA Isolation and Extraction Market
           11.8.3    Financials
           11.8.4    Key Insights About the Financial Health of the Company
           11.8.5    SWOT Analysis
11.9    Merck KGaA
           11.9.1    Company Overview
           11.9.2    Role of Merck KGaA in the Global Cell-Free DNA Isolation and Extraction Market
           11.9.3    Financials
           11.9.4    Key Insights About the Financial Health of the Company
           11.9.5    SWOT Analysis
11.10    Illumina, Inc.
             11.10.1    Company Overview
             11.10.2    Role of Illumina, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
             11.10.3    Financials
             11.10.4    Key Insights About the Financial Health of the Company
             11.10.5    SWOT Analysis
11.11    Takara Bio Inc.
             11.11.1    Company Overview
             11.11.2    Role of Takara Bio Inc. in the Global Cell-Free DNA Isolation and Extraction Market
             11.11.3    Financials
             11.11.4    Key Insights About the Financial Health of the Company
             11.11.5    SWOT Analysis
11.12    Aline Biosciences
             11.12.1    Company Overview
             11.12.2    Role of Aline Biosciences in the Global Cell-Free DNA Isolation and Extraction Market
             11.12.3    SWOT Analysis
11.13    EpiGentek Group, Inc.
             11.13.1    Company Overview
             11.13.2    Role of EpiGentek Group, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
             11.13.3    SWOT Analysis
11.14    Omega Bio-tek, Inc.
             11.14.1    Company Overview
             11.14.2    Role of Omega Bio-tek, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
             11.14.3    SWOT Analysis
11.15    Promega Corporation
             11.15.1    Company Overview
             11.15.2    Role of Promega Corporation in the Global Cell-Free DNA Isolation and Extraction Market
             11.15.3    SWOT Analysis
11.16    Streck, Inc.
             11.16.1    Company Overview
             11.16.2    Role of Streck, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
             11.16.3    SWOT Analysis
11.17    AccuBioMed Co., Ltd.
             11.17.1    Company Overview
             11.17.2    Role of AccuBioMed Co., Ltd. in the Global Cell-Free DNA Isolation and Extraction Market
11.18    AMSBIO
             11.18.1    Company Overview
             11.18.2    Role of AMSBIO in the Global Cell-Free DNA Isolation and Purification Market
11.19    Covaris, Inc.
             11.19.1    Role of Covaris, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
11.20    EntroGen, Inc.
             11.20.1    Role of EntroGen, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
11.21    NeoGeneStar LLC
             11.21.1    Company Overview
             11.21.2    Role of NeoGeneStar LLC in the Global Cell-Free DNA Isolation and Extraction Market
11.22    Norgen Biotek Corp.
             11.22.1    Company Overview
             11.22.2    Role of Norgen Biotek Corp. in the Global Cell-Free DNA Isolation and Extraction Market
11.23    STRATEC SE
             11.23.1    Company Overview
             11.23.2    Role of STRATEC SE in the Global Cell-Free DNA Isolation and Extraction Market
11.24    System Biosciences, LLC
             11.24.1    Company Overview
             11.24.2    Role of System Biosciences, LLC in the Global Cell-Free DNA Isolation and Extraction Market
11.25    Vela Diagnostics
             11.25.1    Company Overview
             11.25.2    Role of Vela Diagnostics in the Global Cell-Free DNA Isolation and Extraction Market

Table 1:    Classification of Medical Device
Table 2:    Likert Scale
Table 3:    Impact Analysis of Market Drivers
Table 4:    Impact Analysis of Market Restraints
Table 5:    Cell-Free DNA Isolation and Extraction Tubes Offered by Key Market Players
Table 6:    List of Kits Using Spin Column-Based Technique

Figure 1:    Global Cancer Burden, 2020
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on the Global Cell-Free DNA Isolation and Extraction Market
Figure 3:    Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031
Figure 4:    Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031
Figure 5:    Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031
Figure 6:    Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031
Figure 7:    Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031
Figure 8:    Global Cell-Free DNA Isolation and Extraction Market Snapshot
Figure 9:    Global Cell-Free DNA Isolation and Extraction Market: Research Methodology
Figure 10:    Primary Research Methodology
Figure 11:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 12:    Top-Down Approach (Segment-Wise Analysis)
Figure 13:    Global Cell-Free DNA Isolation and Extraction Market Segmentation
Figure 14:    Global Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 15:    Global Cell-Free DNA Isolation and Extraction Market: COVID-19 Impact Analysis
Figure 16:    Overview of Regulatory Process for Medical Devices by FDA
Figure 17:    Overview of Regulatory Process for Medical Devices in Europe
Figure 18:    Overview of Regulatory Process for Medical Devices by National Medical Product Administration
Figure 19:    Global Cancer Burden, 2020
Figure 20:    Share of Key Developments, January 2018-November 2021
Figure 21:    Share of Product Launch and Upgradations (by Company), January 2018-November 2021
Figure 22:    Share of Product Approvals and Business Funding (by Company), January 2018-November 2021
Figure 23:    Share of Synergistic Activities (by Company), January 2018-November 2021
Figure 24:    Market Share Analysis of Global Cell-Free DNA Isolation and Extraction Market (by Company), 2019 and 2020
Figure 25:    Growth Share Analysis for Global Cell-Free DNA Isolation and Extraction Market (by Company), 2020
Figure 26:    Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Consumable)
Figure 27:    Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031
Figure 28:    Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), $Million, 2020-2031
Figure 29:    Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), Unit, 2020-2031
Figure 30:    Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Tubes), $Million, 2020-2031
Figure 31:    Global Cell-Free DNA Isolation and Extraction Market (Other Consumables), $Million, 2020-2031
Figure 32:    Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Platform)
Figure 33:    Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031
Figure 34:    Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing), $Million, 2020-2031
Figure 35:    Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing (NGS)), Unit, 2020-2031
Figure 36:    Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), $Million, 2020-2031
Figure 37:    Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), Unit, 2020-2031
Figure 38:    Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), $Million, 2020-2031
Figure 39:    Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), Unit, 2020-2031
Figure 40:    Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR)), $Million, 2020-2031
Figure 41:    Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR), Unit, 2020-2031
Figure 42:    Global Cell-Free DNA Isolation and Extraction Market (Other Platforms), $Million, 2020-2031
Figure 43:    Global Cell-free DNA Isolation and Extraction Market (Other Platforms), Unit, 2020-2031
Figure 44:    Global Cell-Free DNA Isolation and Extraction Market (by Technique)
Figure 45:    Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031
Figure 46:    Global Cell-Free DNA Isolation and Extraction Market (Magnetic Beads-Based Technique), $Million, 2020-2031
Figure 47:    Global Cell-Free DNA Isolation and Extraction Market (Spin Column-Based Technique), $Million, 2020-2031
Figure 48:    Global Cell-Free DNA Isolation and Extraction Market (Other Techniques), $Million, 2020-2031
Figure 49:    Global Cell-Free DNA Isolation and Extraction Market (by Application)
Figure 50:    Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031
Figure 51:    Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT)), $Million, 2020-2031
Figure 52:    Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT), Unit, 2020-2031
Figure 53:    Global Cell-Free DNA Isolation and Extraction Market (Oncology), $Million, 2020-2031
Figure 54:    Global Cell-Free DNA Isolation and Extraction Market (Oncology), Unit, 2020-2031
Figure 55:    Global Cell-Free DNA Isolation and Extraction Market (Solid Tumor), $Million, 2020-2031
Figure 56:    Global Cell-Free DNA Isolation and Extraction Market (Hematological Malignancies), $Million, 2020-2031
Figure 57:    Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), $Million, 2020-2031
Figure 58:    Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), Unit, 2020-2031
Figure 59:    Global Cell-Free DNA Isolation and Extraction Market (Other Applications), $Million, 2020-2031
Figure 60:    Global Cell-Free DNA Isolation and Extraction Market (Other Applications), Unit, 2020-2031
Figure 61:    Global Cell-Free DNA Isolation and Extraction Market (by End User)
Figure 62:    Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031
Figure 63:    Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
Figure 64:    Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), Unit, 2020-2031
Figure 65:    Global Cell-Free DNA Isolation and Extraction Market (Academic Research Institutes and Laboratories), $Million, 2020-2031
Figure 66:    Global Cell-Free DNA Isolation and Extraction Market (Academic and Research Institutes and Laboratories), Unit, 2020-2031
Figure 67:    Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), $Million, 2020-2031
Figure 68:    Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), Unit, 2020-2031
Figure 69:    Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), $Million, 2020-2031
Figure 70:    Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), Unit, 2020-2031
Figure 71:    Global Cell-Free DNA Isolation and Extraction Market (Other End Users), $Million, 2020-2031
Figure 72:    Global Cell-Free DNA Isolation and Extraction Market (Other End Users), Unit, 2020-2031
Figure 73:    Global Cell-Free DNA Isolation and Extraction Market Snapshot (by Region), $Million, 2020-2031
Figure 74:    Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020-2031
Figure 75:    Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020 and 2031
Figure 76:    North America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 77:    North America: Market Dynamics
Figure 78:    North America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
Figure 79:    North America Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 80:    U.S. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 81:    U.S. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 82:    U.S. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 83:    Canada Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 84:    Canada Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 85:    Canada Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 86:    Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 87:    Europe: Market Dynamics
Figure 88:    Europe Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
Figure 89:    Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 90:    Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
Figure 91:    Germany Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 92:    Germany Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 93:    Germany Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
Figure 94:    France Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 95:    France Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 96:    France Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
Figure 97:    U.K. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 98:    U.K. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 99:    U.K. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 100:    Italy Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 101:    Italy Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 102:    Italy Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 103:    Spain Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 104:    Spain Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 105:    Spain Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
Figure 106:    Denmark Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 107:    Denmark Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 108:    Denmark Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
Figure 109:    Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 110:    Rest-of-Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
Figure 111:    Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
Figure 112:    Asia-Pacific Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 113:    Asia-Pacific: Market Dynamics
Figure 114:    APAC Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
Figure 115:    China Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 116:    India Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 117:    Japan Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 118:    South Korea Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 119:    Australia Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 120:    Singapore Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 121:    RoAPAC Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 122:    Latin America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 123:    Latin America: Market Dynamics
Figure 124:    Latin America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
Figure 125:    Brazil Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 126:    Mexico Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 127:    Rest-of-Latin America (RoLA) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 128:    Rest-of-the-World (RoW) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
Figure 129:    Total Number of Companies Profiled
Figure 130:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 131:    Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 132:    Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 133:    Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020
Figure 134:    Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 135:    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 136:    QIAGEN: Product Portfolio
Figure 137:    QIAGEN: Overall Financials, $Million, 2018-2020
Figure 138:    QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020
Figure 139:    QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
Figure 140:    QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
Figure 141:    QIAGEN N.V.: SWOT Analysis
Figure 142:    Danaher: Product Portfolio
Figure 143:    Danaher Corporation: Overall Financials, $Million, 2018-2020
Figure 144:    Danaher: Revenue (by Segment), $Million, 2018-2020
Figure 145:    Danaher: Revenue (by Region), $Million, 2018-2020
Figure 146:    Danaher: R&D Expenditure, $Million, 2018-2020
Figure 147:    Danaher: SWOT Analysis
Figure 148:    PerkinElmer, Inc.: Product Portfolio
Figure 149:    PerkinElmer, Inc.: Overall Financials, $Million, 2018-2020
Figure 150:    PerkinElmer, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 151:    PerkinElmer, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 152:    PerkinElmer, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 153:    PerkinElmer, Inc.: SWOT Analysis
Figure 154:    Endress+Hauser AG: Product Portfolio
Figure 155:    Endress+Hauser AG: Overall Financials, $Million, 2018-2020
Figure 156:    Endress+Hauser AG: Revenue (by Segment), $Million, 2018-2020
Figure 157:    Endress+Hauser AG: Revenue (by Region), $Million, 2018-2020
Figure 158:    Endress+Hauser AG: R&D Expenditure, $Million, 2018-2020
Figure 159:    Endress+Hauser AG: SWOT Analysis
Figure 160:    Agilent Technologies, Inc.: Product Portfolio
Figure 161:    Agilent Technologies, Inc.: Overall Financials, $Million, 2018-2020
Figure 162:    Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 163:    Agilent Technologies, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 164:    Agilent Technologies, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 165:    Agilent Technologies, Inc.: SWOT Analysis
Figure 166:    F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 167:    F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2018-2020
Figure 168:    F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2018-2020
Figure 169:    F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2018-2020
Figure 170:    F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2018-2020
Figure 171:    F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 172:    Merck KGaA: Product Portfolio
Figure 173:    Merck KGaA: Overall Financials, $Million, 2018-2020
Figure 174:    Merck KGaA: Revenue (by Segment), $Million, 2018-2020
Figure 175:    Merck KGaA: Revenue (by Region), $Million, 2018-2020
Figure 176:    Merck KGaA: R&D Expenditure, $Million, 2018-2020
Figure 177:    Merck KGaA: SWOT Analysis
Figure 178:    Illumina, Inc.: Product Portfolio
Figure 179:    Illumina, Inc.: Overall Financials, $Million, 2018-2020
Figure 180:    Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 181:    Illumina, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 182:    Illumina, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 183:    Illumina, Inc.: SWOT Analysis
Figure 184:    Takara Bio Inc.: Product Portfolio
Figure 185:    Takara Bio Inc.: Overall Financials, $Million, 2018-2020
Figure 186:    Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 187:    Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020
Figure 188:    Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021
Figure 189:    Takara Bio Inc.: SWOT Analysis
Figure 190:    Aline Biosciences: Product Portfolio
Figure 191:    Aline Biosciences: SWOT Analysis
Figure 192:    EpiGentek Group, Inc.: Product Portfolio
Figure 193:    EpiGentek Group, Inc.: SWOT Analysis
Figure 194:    Omega Bio-tek, Inc.: Product Portfolio
Figure 195:    Omega Bio-tek, Inc.: SWOT Analysis
Figure 196:    Promega Corporation: Product Portfolio
Figure 197:    Promega Corporation: SWOT Analysis
Figure 198:    Streck, Inc.: Product Portfolio
Figure 199:    Streck, Inc.: SWOT Analysis
Figure 200:    AccuBioMed Co., Ltd.: Product Portfolio
Figure 201:    AMSBIO: Product Portfolio
Figure 202:    Covaris, Inc.: Product Portfolio
Figure 203:    EntroGen, Inc.: Product Portfolio
Figure 204:    NeoGeneStar LLC: Product Portfolio
Figure 205:    Norgen Biotek Corp.: Product Portfolio
Figure 206:    STRATEC SE: Product Portfolio
Figure 207:    System Biosciences, LLC: Product Portfolio
Figure 208:    Vela Diagnostics: Product Portfolio

 
 

Market Report Coverage

Cell-Free DNA Isolation and Extraction Market

Base Year

2020

Market Size in 2021

$195.0 Million

Forecast Period

2021-2031

Value Projection and Estimation by 2031

$735.1 Million

CAGR During Forecast Period

14.19%

Number of Tables

06

Number of Pages

230

Number of Figures

208

Market Segmentation

•    Consumable - Cell-Free DNA Isolation and Extraction Kits, ell-Free DNA Isolation and Extraction Tubes, and Other Consumables

•    Platform - Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms

•    Technique - Magnetic Beads-Based, Spin Column-Based, and Other Techniques

•    Application - Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications

•    End-User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Other End Users

Regional Segmentation

•    North America - U.S., Canada

•    Europe - Germany, U.K., France, Italy, Spain, Denmark, and Rest-of-Europe

•    Asia-Pacific - China, India, Japan, Singapore, South Korea, Australia, and Rest-of-Asia-Pacific

•    Rest-of-the-World

Market Growth Drivers

•    Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer

•    Strategic Initiatives by Key Market Players

•    Rise in the Field of Microbial Sequencing

Market Challenges

•    High Cost of Automated Instruments

•    Genomic Data Protection

•    Rigid Regulatory Standards

Market Opportunities

•    Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction

•    Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

Key Companies Profiled

Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela Diagnostics

Key Questions Answered in this Report:

•    How is cell-free DNA isolation and extraction revolutionizing oncology?
•    What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
•    What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
•    How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?
•    What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
•    What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?
•    What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? 
•    How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
        o    Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables)
        o    Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms)
        o    Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques)
        o    Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications)
        o    End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users)
        o    Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
•    What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
•    Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market? 
•    Which companies are anticipated to be highly disruptive in the future, and why?

Report Summary

Market Overview

The use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market. The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market. The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.

Competitive Landscape

The global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types. Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.

FAQ's

What is the estimated growth rate of the cell-free DNA isolation and extraction market in the coming years?

The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.

Which are the top market players operating in the cell-free DNA isolation and extraction market?

The top market players are Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela Diagnostics.

What are the factors driving the growth of the cell-free DNA isolation and extraction market?

Factors driving the growth of the cell-free DNA isolation and extraction market are cell-free DNA isolation and extraction inclined by rising prevalence of cancer, strategic initiatives by key market players, and rise in the field of microbial sequencing.

What are the challenges restricting the growth of the cell-free DNA isolation and extraction market?

Some of the main challenges restricting the growth of the cell-free DNA isolation and extraction market are high cost of automated instruments, genomic data protection, and rigid regulatory standards.

What are some of the opportunities in the cell-free DNA isolation and extraction market?

The potential opportunities that are likely to boost the growth of the cell-free DNA isolation and extraction market are technological advancement toward innovation in cell-free DNA isolation and extraction, and massive scope for adoption of NGS-based genetic tests in emerging market.

You may also like

Published Year: 2021

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Test, Platform, End User, Appli

The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61...

 

Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis

Focus on Consumables, Platform, Techniques, Application, End User, and Region - Analysis and Forecast, 2021-2031